Canagliflozin and risk of amputation in patients with type 2 diabetes
Canagliflozin and risk of amputation in patients with type 2 diabetes
Blog Article
Sodium jolly rancher lemonade stand glucose co-transporter type 2 inhibitors (SGLT2) are a new effective group of oral hypoglygemic drugs for the treatment of diabetes type 2.At the moment there is no unanimous opinion on their safety.The article presents 310.32.42.50.01.001 the data on clinical studies CANVAS and CANVAS-R and reports of the international database VigiBase (2015 - 2017) on the risk of amputation in patients with type 2 diabetes undergoing treatment with canagliflozin.
Report this page